Enlivex Therapeutics
ENLV
ENLV
26 hedge funds and large institutions have $3.08M invested in Enlivex Therapeutics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
23% less capital invested
Capital invested by funds: $3.99M → $3.08M (-$911K)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
26
Holding in Top 10
–
Calls
$45K
Puts
$7K
Top Buyers
| 1 | +$68K | |
| 2 | +$65.9K | |
| 3 | +$34.1K | |
| 4 |
Renaissance Technologies
New York
|
+$21.6K |
| 5 |
VF
Virtu Financial
New York
|
+$17K |
Top Sellers
| 1 | -$413K | |
| 2 | -$37.8K | |
| 3 | -$11.7K | |
| 4 |
HF
HRT Financial
New York
|
-$5.92K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$2.17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $16 |
|
|||
|
AWAG
27
ARS Wealth Advisors Group
St. Petersburg,
Florida
| – |
|
|||
|
SWM
28
Spire Wealth Management
Mclean,
Virginia
| – |
|